OPC-34712FUM/ Brexpiprazole fumarate
Sponsors
Otsuka Pharmaceutical Co., Ltd.
Conditions
Acute SchizophreniaSchizophrenia
Phase 1
Phase 3
A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
CompletedNCT05326347
Start: 2022-05-31End: 2025-09-30Updated: 2026-09-11
Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
RecruitingNCT05325645
Start: 2022-07-21End: 2027-10-01Target: 450Updated: 2026-09-16